Bortezomib and carfilzomib are anticancer drugs that target the proteasome. However, these
agents have been shown to exhibit some specific cardiac toxicities by as yet unknown …

Ubiquitination is one of the post translational modifications which decide the fate of various
proteins in the cells, by either directing them towards proteasomal degradation or …

Bortezomib (Velcade®) came into the spotlight as a target therapy for multiple myeloma. It
acts through reversible inhibition of intracellular proteasomes, which triggers apoptosis, with …

Muscle growth is advantageous not only because of its roles in mobility and breathing, but
because increases in muscle mass increase physical strength, reduces the risk of injury …

Bortezomib is an important proteasome inhibitor widely used in plasma cell neoplasms. An
acute cardiac dysfunction is not a frequent side effect of bortezomib, but it is mentioned in …

Bortezomib (Velcade®) came into the spotlight as a target therapy for multiple myeloma. It
acts through reversible inhibition of intracellular proteasomes, which triggers apoptosis, with …